Please try another search
WASHINGTON, Sept. 19, 2024 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2024 on Tuesday,...
BREA, Calif. and TEL AVIV, Israel, Sept. 17, 2024 /PRNewswire/ -- Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow...
WASHINGTON, Sept. 10, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common...
Danaher (NYSE:DHR) declared a quarterly dividend of $0.27 per share, or $1.08 annualized. The dividend will be payable on October 25, 2024, to stockholders of record on September 27, 2024, with an...
On Friday, TD Cowen maintained a positive outlook on shares of Danaher Corporation (NYSE:DHR), reiterating a Buy rating and a price target of $310.00. The endorsement follows a recent investor day...
WASHINGTON - Danaher Corporation (NYSE:DHR), a global life sciences and diagnostics company, reaffirmed its financial guidance for the third quarter and the full year of 2024 today. The company...
Danaher Corporation (NYSE:DHR) (the "Company") confirmed its previously issued guidance for the third quarter and full year 2024 ahead of a previously scheduled analyst event. The Company provides...
In a recent transaction, Georgeann Couchara, Senior Vice President of Human Resources at Danaher Corp (NYSE:DHR), sold 952 shares of the company's common stock. The sale, which took place on August...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review